Lactam containing HCV inhibitors

Details for Australian Patent Application No. 2006342209 (hide)

Owner Novartis AG

Inventors Ni, Zhi-Jie; Weiner, Amy; Chang, Bryan; Brammier, Nathan; Wang, Weibo; Barsanti, Paul

Agent Davies Collison Cave

Pub. Number AU-A-2006342209

PCT Pub. Number WO2007/120160

Priority 60/692007 16.06.05 US

Filing date 16 June 2006

Wipo publication date 25 October 2007

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/120160 Priority application(s): WO2007/120160

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006342218-Compositions and methods for treating gram positive bacterial infection in a mammalian subject

2006342202-Compositions and methods for cellular imaging and therapy